AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25138681 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch applied to buttocks
Number of subjects: 43
Study 25138681 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch applied to outer upper arm
Number of subjects: 43
Study 25138681 — intervention group
Group type: COMPARATOR
Intervention: Transdermal contraceptive patch applied to lower abdomen
Number of subjects: 43
Study 25138681 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch applied to any site
Number of subjects: 43
Study 22732964 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupinus mutabilis
Number of subjects: 2
Study 22732964 — intervention group
Group type: COMPARATOR
Intervention: Soy (control)
Number of subjects: 2
Study 19908948 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisoprodol 250 mg
Number of subjects: 264
Study 19908948 — intervention group
Group type: COMPARATOR
Intervention: Carisoprodol 350 mg
Number of subjects: 264
Study 19908948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 17548761 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent health promotion intervention program
Number of subjects: 978
Study 17548761 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 978
Study 15378438 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 400 mg (base) daily for 3 days, followed by single monthly 400-mg doses (n = 104)
Number of subjects: 205
Study 15378438 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 101)
Number of subjects: 205
Study 11162345 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal contact behavioral intervention using the Stage‐of‐Change concept
Number of subjects: 530
Study 11162345 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment condition
Number of subjects: 530
Study 10186498 — intervention group
Group type: EXPERIMENTAL
Intervention: Young subjects
Number of subjects: 0
Study 10186498 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly subjects
Number of subjects: 0
Study 10186498 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience
Number of subjects: 0
Study 7976902 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D TOF MR angiography (MPR)
Number of subjects: 20
Study 7976902 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D TOF MR angiography (MIPs)
Number of subjects: 20
Study 7976902 — intervention group
Group type: EXPERIMENTAL
Intervention: MOTSA MR angiogram
Number of subjects: 20
Study 7976902 — intervention group
Group type: COMPARATOR
Intervention: Intraarterial angiography
Number of subjects: 20
Study 2485152 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclooxygenase inhibitors (azapropazone) and aprotinin
Number of subjects: 0
Study 2485152 — intervention group
Group type: COMPARATOR
Intervention: Non-steroidal antiphlogistic drugs
Number of subjects: 0
Study 1148993 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose preoperative irradiation (2000-2500 rads/10 fractions/12 days)
Number of subjects: 700
Study 1148993 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose preoperative irradiation (3150 rads)
Number of subjects: 700
Study 1148993 — intervention group
Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 700
Study 30587066 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised resistance training
Number of subjects: 156
Study 28666682 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-led rehabilitation training (structured training including information provision, joint goal setting, carer training, and task-specific training) for up to 2 months initiated in hospital and continued at home.
Number of subjects: 1250
Study 28666682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1250
Study 28666682 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-led rehabilitation training (intervention group).
Number of subjects: 1250
Study 26307620 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based smoke-free intervention (SFI) consisting of six interactive educational activities.
Number of subjects: 360
Study 26307620 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual education.
Number of subjects: 360
Study 22476244 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 37
Study 22476244 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine sulfate (1,500 mg/day) plus exercise therapy
Number of subjects: 37
Study 22189721 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 199
Study 22189721 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 199
Study 19502478 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Skills with Behavioral Couples Therapy (PSBCT)
Number of subjects: 30
Study 19502478 — intervention group
Group type: COMPARATOR
Intervention: Behavioral Couples Therapy (BCT)
Number of subjects: 30
Study 19502478 — intervention group
Group type: COMPARATOR
Intervention: Individual‐Based Treatment (IBT)
Number of subjects: 30
Study 16861432 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive intravascular fluid balance of 0-1000 mL (Group 1)
Number of subjects: 32
Study 16861432 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive intravascular fluid balance of 1000-2000 mL (Group 2)
Number of subjects: 32
Study 16861432 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive fluid balance
Number of subjects: 32
Study 16861432 — intervention group
Group type: COMPARATOR
Intervention: Restricted intravascular fluid balance
Number of subjects: 32
Study 12942587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) 500 mg
Number of subjects: 15
Study 12942587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17069099 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0
Study 17069099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10588144 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) active for the first 4 weeks, then withheld for the next 4 weeks.
Number of subjects: 24
Study 10588144 — intervention group
Group type: COMPARATOR
Intervention: Control group with SCS switched off for 4 weeks before the end of the study.
Number of subjects: 24
Study 8767376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical lavage with 2 l of polyethylene glycol (PEG) solution combined with a laxative (group A, n = 50)
Number of subjects: 100
Study 8767376 — intervention group
Group type: COMPARATOR
Intervention: Lavage with 4 l of PEG alone (group B, n = 50)
Number of subjects: 100
Study 8767376 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional surgery
Number of subjects: 100
Study 1672547 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 35
Study 1672547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 6752563 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg dimethpyrindene (Fenistil) and 5 mg/kg cimetidine (Tagamet)
Number of subjects: 0
Study 6752563 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg dimethpyrindene and 10 mg/kg cimetidine
Number of subjects: 0
Study 6752563 — intervention group
Group type: EXPERIMENTAL
Intervention: H1- + H2-receptor antagonists
Number of subjects: 0
Study 31800611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (30 mg) before surgery
Number of subjects: 203
Study 31800611 — intervention group
Group type: COMPARATOR
Intervention: Placebo before surgery
Number of subjects: 203
Study 28286194 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal tacrolimus (0.5 mg/mL)
Number of subjects: 21
Study 26025215 — intervention group
Group type: EXPERIMENTAL
Intervention: SALdável Program intervention
Number of subjects: 92
Study 26025215 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 24097340 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.5 %
Number of subjects: 60
Study 24097340 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5 %
Number of subjects: 60
Study 23031464 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 (125 mg PFA/kg BD)
Number of subjects: 525
Study 23031464 — intervention group
Group type: EXPERIMENTAL
Intervention: E3 (250 mg PFA/kg BD)
Number of subjects: 525
Study 23031464 — intervention group
Group type: COMPARATOR
Intervention: C (BD based on maize‐soybean meal with no other additions)
Number of subjects: 525
Study 23031464 — intervention group
Group type: EXPERIMENTAL
Intervention: PFA inclusion level
Number of subjects: 525
Study 19534614 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigowood root (IR)
Number of subjects: 20
Study 19534614 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 20
Study 17428602 — intervention group
Group type: EXPERIMENTAL
Intervention: Panoramic visor respirator
Number of subjects: 14
Study 17428602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-ocular respirator
Number of subjects: 14
Study 17428602 — intervention group
Group type: COMPARATOR
Intervention: Control (unprotected)
Number of subjects: 14
Study 15321802 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of > or =2 servings of fish per week
Number of subjects: 229
Study 15321802 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of > or =1 serving of tuna or dark fish per week
Number of subjects: 229
Study 15321802 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fish consumption
Number of subjects: 229
Study 11448249 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (4, 6, and 8 mcg/kg/day)
Number of subjects: 10
Study 11448249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9514534 — intervention group
Group type: EXPERIMENTAL
Intervention: Pringle's maneuver
Number of subjects: 20
Study 7985256 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline 300 mg b.i.d.
Number of subjects: 48
Study 30479242 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative shared care (CSC) program between traditional and faith healers (T&FHs) and biomedical providers for the treatment of psychotic disorders
Number of subjects: 35
Study 30479242 — intervention group
Group type: EXPERIMENTAL
Intervention: Training workshops for early and mid-career researchers
Number of subjects: 35
Study 30479242 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring for early career researchers
Number of subjects: 35
Study 30479242 — intervention group
Group type: EXPERIMENTAL
Intervention: Research capacity building
Number of subjects: 35
Study 28189771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg (2 puffs of 2.5 μg)
Number of subjects: 401
Study 28189771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg (2 puffs of 1.25 μg)
Number of subjects: 401
Study 28189771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 puffs)
Number of subjects: 401
Study 25915834 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical EBI-005 (5 mg/mL)
Number of subjects: 159
Study 25915834 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 159
Study 23635736 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate surgery (n=64)
Number of subjects: 578
Study 23635736 — intervention group
Group type: COMPARATOR
Intervention: Individually tailored therapy (n=62)
Number of subjects: 578
Study 22011408 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery
Number of subjects: 12
Study 22011408 — intervention group
Group type: COMPARATOR
Intervention: Conventional CSII
Number of subjects: 12
Study 18385391 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacinamide (500 to 1500 mg/d)
Number of subjects: 33
Study 18385391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 18385391 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacinamide (500 to 1500 mg/d) among compliant patients
Number of subjects: 33
Study 18385391 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 16437738 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect moxibustion on acupuncture points ST‐36 and SP‐6 for 20 minutes per day for 1 week
Number of subjects: 24
Study 12915954 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol (100 mg)
Number of subjects: 11
Study 12915954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 10691755 — intervention group
Group type: EXPERIMENTAL
Intervention: Community programme (media advocacy, youth anti-tobacco activities, family communications about tobacco use, reduction of youth access to tobacco)
Number of subjects: 1700
Study 10691755 — intervention group
Group type: EXPERIMENTAL
Intervention: Community programme
Number of subjects: 1700
Study 10691755 — intervention group
Group type: COMPARATOR
Intervention: School based prevention programme
Number of subjects: 1700
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study 9137841 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake blockers
Number of subjects: 0
Study 8212819 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of B-WC vaccine at 7, 14, or 28-42 day intervals
Number of subjects: 0
Study 8212819 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of B-WC vaccine at 3-day intervals
Number of subjects: 0
Study 8212819 — intervention group
Group type: EXPERIMENTAL
Intervention: Different time intervals tested (3-42 days) for vibriocidal antibody responses
Number of subjects: 0
Study 8212819 — intervention group
Group type: EXPERIMENTAL
Intervention: B-WC vaccine with sodium bicarbonate powder
Number of subjects: 0
Study 3940333 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle breast stimulation for 1.5 hours in hospital and then for three hours daily for three days at home.
Number of subjects: 100
Study 3940333 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle breast stimulation for the same period of time and under the same conditions (after crossover).
Number of subjects: 100
Study 3940333 — intervention group
Group type: COMPARATOR
Intervention: Control group (no breast stimulation).
Number of subjects: 100
Study 3940333 — intervention group
Group type: COMPARATOR
Intervention: Extreatment group (previously stimulated group during crossover).
Number of subjects: 100
Study 31996978 — intervention group
Group type: COMPARATOR
Intervention: FV+ (standard food parcel plus the recommended daily amount of fruit and vegetables)
Number of subjects: 163
Study 31996978 — intervention group
Group type: COMPARATOR
Intervention: Snacks-+FV+ (standard food parcel with replacement of unhealthy snacks by staple foods plus the recommended daily amount of fruit and vegetables)
Number of subjects: 163
Study 31996978 — intervention group
Group type: COMPARATOR
Intervention: Snacks- (standard food parcel with replacement of unhealthy snacks by staple foods)
Number of subjects: 163
Study 29731121 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for HFrEF
Number of subjects: 4024
Study 27833172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry supplementation (1500 mg cranberry fruit powder for a mean of 30 days)
Number of subjects: 64
Study 27833172 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar amount as cranberry group)
Number of subjects: 64
Study 25460722 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive-type resistance training (EMRT) for 12 weeks
Number of subjects: 16
Study 25460722 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive-type resistance training (EMRT)
Number of subjects: 16
Study 25460722 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exercising)
Number of subjects: 16
Study 23328238 — intervention group
Group type: EXPERIMENTAL
Intervention: MC + PEEK cage
Number of subjects: 51
Study 23328238 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical plate with PEEK cage or titanium mesh
Number of subjects: 51
Study 20123819 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 179
Study 20123819 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study 19289436 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-time (HT) gated myocardial SPECT images processed with OSEM-RR plus AC
Number of subjects: 212
Study 19289436 — intervention group
Group type: COMPARATOR
Intervention: Full-time (FT) gated myocardial SPECT images processed with FBP and OSEM
Number of subjects: 212
Study 19289436 — intervention group
Group type: COMPARATOR
Intervention: Test-retest repeatability using FT images (FBP reconstruction)
Number of subjects: 212
Study 19289436 — intervention group
Group type: EXPERIMENTAL
Intervention: HT images processed with the new algorithm
Number of subjects: 212
Study 15838756 — intervention group
Group type: EXPERIMENTAL
Intervention: (3)He‐MRI
Number of subjects: 14
Study 15838756 — intervention group
Group type: COMPARATOR
Intervention: HRCT
Number of subjects: 14
Study 12913704 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 M KCl
Number of subjects: 78
Study 12913704 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 78
Study 10485720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine 200 mg orally at onset of labour and 2 mg/kg to babies within 72 h of birth
Number of subjects: 626
Study 10485720 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine 600 mg orally to the mother at onset of labour and 300 mg every 3 h until delivery, and 4 mg/kg orally twice daily to babies for 7 days after birth
Number of subjects: 626
Study 8941752 — intervention group
Group type: COMPARATOR
Intervention: Pulpectomy alone
Number of subjects: 17
Study 8941752 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpectomy with trephination
Number of subjects: 17
Study 2007938 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal)
Number of subjects: 419
Study 2007938 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 419
Study 6128282 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pseudoephedrine and triprolidine administered every 6 hours
Number of subjects: 0
Study 6128282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6128282 — intervention group
Group type: COMPARATOR
Intervention: Triprolidine
Number of subjects: 0
Study 6128282 — intervention group
Group type: COMPARATOR
Intervention: Pseudoephedrine
Number of subjects: 0
Study 31981056 — intervention group
Group type: EXPERIMENTAL
Intervention: FNS (fans and showers)
Number of subjects: 36
Study 31981056 — intervention group
Group type: COMPARATOR
Intervention: CTL (shade only)
Number of subjects: 36
Study 31981056 — intervention group
Group type: EXPERIMENTAL
Intervention: FN (fans only)
Number of subjects: 36
Study 29453374 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB group
Number of subjects: 2
Study 29453374 — intervention group
Group type: COMPARATOR
Intervention: non-ARB group
Number of subjects: 2
Study 26742062 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal hydrolysed whey protein at 2.1 kJ/min
Number of subjects: 16
Study 26742062 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal hydrolysed whey protein at 6.3 kJ/min
Number of subjects: 16
Study 26742062 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal hydrolysed whey protein at 12.5 kJ/min
Number of subjects: 16
Study 26742062 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 16
Study 24290597 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (600 mg of elemental Ca/d as CaCO3)
Number of subjects: 26
Study 24290597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 22771100 — intervention group
Group type: EXPERIMENTAL
Intervention: 3F pancreatic duct stent (PS) placement
Number of subjects: 101
Study 22771100 — intervention group
Group type: COMPARATOR
Intervention: Non-stent (NS) group
Number of subjects: 101
Study 20038323 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 40
Study 20038323 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical practice monitoring
Number of subjects: 40
Study 20038323 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 18663165 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam hydrochloride, 3.75 g/d
Number of subjects: 287
Study 18663165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study 16459895 — intervention group
Group type: EXPERIMENTAL
Intervention: Words with schwa deleted
Number of subjects: 0
Study 16459895 — intervention group
Group type: COMPARATOR
Intervention: Words retaining schwa
Number of subjects: 0
Study 14649577 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 0
Study 14649577 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 0
Study 11107459 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and activity intervention during pregnancy (individual diet counselling, physical activity sessions)
Number of subjects: 219
Study 11107459 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and activity intervention during pregnancy
Number of subjects: 219
Study 8841863 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic paravertebral infusion of bupivacaine (loading dose of 15 mL of 0.375% bupivacaine, plus an infusion of 5 mL of 0.25% bupivacaine every hour)
Number of subjects: 30
Study 8841863 — intervention group
Group type: COMPARATOR
Intervention: Bolus regimen of 20 mL of 0.375% bupivacaine every 6 hours
Number of subjects: 30
Study 1536215 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg micronized 17 beta-estradiol
Number of subjects: 51
Study 1536215 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg micronized 17 beta-estradiol
Number of subjects: 51